<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0002899'>Fatigue</z:mp> is frequent in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> and this symptom appears to be more prominent in type 2 rather than type 1 diabetic subjects </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> represents one characteristic of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> that may contribute to <z:mp ids='MP_0002899'>fatigue</z:mp> symptoms </plain></SENT>
<SENT sid="2" pm="."><plain>This possibility was assessed in a sample of 20 type 2 diabetic patients relatively to a group of 20 type 1 diabetic subjects </plain></SENT>
<SENT sid="3" pm="."><plain>Specific dimensions of <z:mp ids='MP_0002899'>fatigue</z:mp>, including general <z:mp ids='MP_0002899'>fatigue</z:mp>, physical <z:mp ids='MP_0002899'>fatigue</z:mp>, reduced activity, mental <z:mp ids='MP_0002899'>fatigue</z:mp> and reduced motivation, were assessed using the Multidimensional-<z:mp ids='MP_0002899'>Fatigue</z:mp>-Inventory (MFI) </plain></SENT>
<SENT sid="4" pm="."><plain>Biological assays comprised the measurement of serum inflammatory markers [high-sensitive C-reactive-protein (hsCRP), high-sensitive interleukin-6 (hsIL-6), high-sensitive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-<z:mp ids='MP_0001651'>necrosis</z:mp>-factor-α (hsTNF-α) and neopterin] </plain></SENT>
<SENT sid="5" pm="."><plain>Clinical parameters including indexes of <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> were collected </plain></SENT>
<SENT sid="6" pm="."><plain>In comparison to type 1 diabetic subjects, patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> exhibited higher <z:mp ids='MP_0002899'>fatigue</z:mp> scores, notably in the dimensions of general <z:mp ids='MP_0002899'>fatigue</z:mp>, physical <z:mp ids='MP_0002899'>fatigue</z:mp> and reduced activity, together with greater levels of inflammatory markers that correlated with indexes of <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Regression analyses controlling for <z:mp ids='MP_0002055'>diabetes</z:mp> duration, insulin treatment status, glycemic control and fasting status, indicated that levels of inflammatory markers, in particular hsIL-6, hsCRP and neopterin, were associated with MFI <z:mp ids='MP_0002899'>fatigue</z:mp> dimensions in type 2 diabetic patients </plain></SENT>
<SENT sid="8" pm="."><plain>Mediation analyses revealed that <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> did not significantly account for the relationship of inflammatory markers with <z:mp ids='MP_0002899'>fatigue</z:mp> scores albeit coefficient regressions decreased somewhat when this variable was controlled for in regression models </plain></SENT>
<SENT sid="9" pm="."><plain>These findings indicate that systemic low-grade <z:mp ids='MP_0001845'>inflammation</z:mp> relates to <z:mp ids='MP_0002899'>fatigue</z:mp> symptoms in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and suggest the involvement of inflammatory processes in the pathophysiology of <z:mp ids='MP_0002055'>diabetes</z:mp>-related <z:mp ids='MP_0002899'>fatigue</z:mp> </plain></SENT>
</text></document>